Nuclear oncology featured strongly in the 2011 issue of Cancer Imaging with 5 reviews, 2 original articles and 3 case reports. Many articles described diagnostic appli-cations of novel or emerging tracers. Stomatostatin receptor scintigraphy provided the focus of 2 original articles and a case report. Jindal et al.[1] (New Delhi, India) evaluated of the role of [18F]FDG-PET/CT and [68Ga]DOTATOC-PET/CT in 20 patients with pulmonary carcinoids and concluded that the differ-ent uptake patterns of the 2 tracers and the ratio of mea-sured uptake may be helpful in differentiating between typical and atypical carcinoids. A case report of concom-itant lung and gastroenteropancreatic neuroendocrine tumours by Kaemmerer et al.[2] (Bad Berka, Germany)...
Abstract. Various tumours, classically specified as either neuroendocrine or non-neuroendocrine, con...
To assess individual treatment options for patients with carcinoid tumours, accurate knowledge of tu...
Cancer affects people worldwide, causing approximately 9.6 million deaths in 2018 globally. Although...
OBJECTIVES: The clinical utility of fluorodeoxyglucose-positron emission tomography (FDG-PET) and so...
Background:68Gallium DOTA-PET imaging is preferable to standard somatostatin receptor scintigraphy w...
C1 - Journal Articles RefereedINTRODUCTION: Ga-68 DOTATATE (Ga-octreotate, GaTate) positron emission...
TO THE EDITOR: We read with great interest the article by Kayani et al. (1). They evaluated 11 cases...
Positron emission tomography (PET) has an approximately 50 year-history. It was developed as a tool ...
(18)F-fluoro-2-deoxy-D-glucose PET-computed tomography (CT) has a major clinical impact in oncology ...
International audienceEditorial on the Research Topic Innovative Radiopharmaceuticals in Oncology an...
The issue of Cancers Journal entitled “Role of Medical Imaging in Cancers” presents a detailed summa...
This article discusses the important role of nuclear medicine imaging and therapy in the management ...
The past three decades have witnessed a radical change in the diagnostic approach to neuroendocrin...
The imaging of neuroendocrine tumors has become one of the most significant areas in nuclear oncolog...
Abstract. Various tumours, classically specified as either neuroendocrine or non-neuroendocrine, con...
To assess individual treatment options for patients with carcinoid tumours, accurate knowledge of tu...
Cancer affects people worldwide, causing approximately 9.6 million deaths in 2018 globally. Although...
OBJECTIVES: The clinical utility of fluorodeoxyglucose-positron emission tomography (FDG-PET) and so...
Background:68Gallium DOTA-PET imaging is preferable to standard somatostatin receptor scintigraphy w...
C1 - Journal Articles RefereedINTRODUCTION: Ga-68 DOTATATE (Ga-octreotate, GaTate) positron emission...
TO THE EDITOR: We read with great interest the article by Kayani et al. (1). They evaluated 11 cases...
Positron emission tomography (PET) has an approximately 50 year-history. It was developed as a tool ...
(18)F-fluoro-2-deoxy-D-glucose PET-computed tomography (CT) has a major clinical impact in oncology ...
International audienceEditorial on the Research Topic Innovative Radiopharmaceuticals in Oncology an...
The issue of Cancers Journal entitled “Role of Medical Imaging in Cancers” presents a detailed summa...
This article discusses the important role of nuclear medicine imaging and therapy in the management ...
The past three decades have witnessed a radical change in the diagnostic approach to neuroendocrin...
The imaging of neuroendocrine tumors has become one of the most significant areas in nuclear oncolog...
Abstract. Various tumours, classically specified as either neuroendocrine or non-neuroendocrine, con...
To assess individual treatment options for patients with carcinoid tumours, accurate knowledge of tu...
Cancer affects people worldwide, causing approximately 9.6 million deaths in 2018 globally. Although...